We design fit-for-purpose preclinical studies and identify the right GLP/AAALAC-compliant CROs to execute them. From species and model justification to dose-range finding, endpoints, and statistics, every plan aligns with regulatory expectations and ethical standards. Our due-diligence process ensures the right lab, the first time — on scope, budget, and quality.